Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and others.
This report contains market size and forecasts of Endocrinology Drugs in global, including the following market information:
- Global Endocrinology Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Endocrinology Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Endocrinology Drugs companies in 2021 (%)
The global Endocrinology Drugs market was valued at 99620 million in 2021 and is projected to reach US$ 140400 million by 2028, at a CAGR of 5.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diabetes Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Endocrinology Drugs include AbbVie, AstraZeneca, Eli Lilly, Merck, Novo Nordisk and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Endocrinology Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endocrinology Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Endocrinology Drugs Market Segment Percentages, by Type, 2021 (%)
- Diabetes Drugs
- Testosterone Replacement Drugs
- Human Growth Hormone Drugs
- Thyroid Hormone Disorder Drugs
Global Endocrinology Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Endocrinology Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Commercial Laboratories
- Ambulatory Care Centres
- Other Setting
Global Endocrinology Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Endocrinology Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Endocrinology Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Endocrinology Drugs revenues share in global market, 2021 (%)
- Key companies Endocrinology Drugs sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Endocrinology Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AbbVie
- AstraZeneca
- Eli Lilly
- Merck
- Novo Nordisk
- Sanofi
